These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33535464)

  • 21. Identification and characterization of novel and rare susceptible variants in Indian amyotrophic lateral sclerosis patients.
    Narain P; Padhi AK; Dave U; Mishra D; Bhatia R; Vivekanandan P; Gomes J
    Neurogenetics; 2019 Oct; 20(4):197-208. PubMed ID: 31432357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical studies of angiogenin in the skin of patients with amyotrophic lateral sclerosis.
    Higashida K; Tsukie T; Fukazawa H; Fujikura M; Ono S
    J Neurol Sci; 2013 Mar; 326(1-2):18-23. PubMed ID: 23351638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis.
    Greenway MJ; Andersen PM; Russ C; Ennis S; Cashman S; Donaghy C; Patterson V; Swingler R; Kieran D; Prehn J; Morrison KE; Green A; Acharya KR; Brown RH; Hardiman O
    Nat Genet; 2006 Apr; 38(4):411-3. PubMed ID: 16501576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of angiogenin function is related to earlier ALS onset and a paradoxical increase in ALS duration.
    Aluri KC; Salisbury JP; Prehn JHM; Agar JN
    Sci Rep; 2020 Feb; 10(1):3715. PubMed ID: 32111867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiogenin mutations in Hungarian patients with amyotrophic lateral sclerosis: Clinical, genetic, computational, and functional analyses.
    Tripolszki K; Danis J; Padhi AK; Gomes J; Bozó R; Nagy ZF; Nagy D; Klivényi P; Engelhardt JI; Széll M
    Brain Behav; 2019 Jun; 9(6):e01293. PubMed ID: 31025543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human angiogenin is a neuroprotective factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of motor neurons.
    Subramanian V; Crabtree B; Acharya KR
    Hum Mol Genet; 2008 Jan; 17(1):130-49. PubMed ID: 17916583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fast prediction of deleterious angiogenin mutations causing amyotrophic lateral sclerosis.
    Padhi AK; Vasaikar SV; Jayaram B; Gomes J
    FEBS Lett; 2013 Jun; 587(12):1762-6. PubMed ID: 23665167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A distant angiogenin variant causes amyotrophic lateral sclerosis through loss-of-function mechanisms: Insights from long-timescale atomistic simulations and conformational dynamics.
    Padhi AK; Shukla R; Narain P; Gomes J
    Comput Biol Med; 2021 Aug; 135():104602. PubMed ID: 34214939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between the Angiogenin (ANG) K17I variant and amyotrophic lateral sclerosis risk in Caucasian: a meta-analysis.
    Pan L; Deng X; Ding D; Leng H; Zhu X; Wang Z
    Neurol Sci; 2015 Dec; 36(12):2163-8. PubMed ID: 26255299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting angiogenin in therapy of amyotropic lateral sclerosis.
    Kishikawa H; Wu D; Hu GF
    Expert Opin Ther Targets; 2008 Oct; 12(10):1229-42. PubMed ID: 18781822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural mechanism of angiogenin activation by the ribosome.
    Loveland AB; Koh CS; Ganesan R; Jacobson A; Korostelev AA
    Nature; 2024 Jun; 630(8017):769-776. PubMed ID: 38718836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A molecular dynamics based investigation reveals the role of rare Ribonuclease 4 variants in amyotrophic lateral sclerosis susceptibility.
    Padhi AK; Gomes J
    Mutat Res; 2019 Jan; 813():1-12. PubMed ID: 30544007
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Akiyama Y; Tomioka Y; Abe T; Anderson P; Ivanov P
    RNA Biol; 2021 Dec; 18(12):2546-2555. PubMed ID: 34085908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unexpected binding mode for 2'-phosphoadenosine-based nucleotide inhibitors in complex with human angiogenin revealed by heteronuclear NMR spectroscopy.
    Tonan K; Xu P; Jenkins JL; Russo A; Shapiro R; Ni F
    Biochemistry; 2003 Sep; 42(38):11137-49. PubMed ID: 14503864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of phosphate and pyrophosphate ions at the active site of human angiogenin as revealed by X-ray crystallography.
    Leonidas DD; Chavali GB; Jardine AM; Li S; Shapiro R; Acharya KR
    Protein Sci; 2001 Aug; 10(8):1669-76. PubMed ID: 11468363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of unique neuropathology in amyotrophic lateral sclerosis associated with p.K54E angiogenin (ANG) mutation.
    Kirby J; Highley JR; Cox L; Goodall EF; Hewitt C; Hartley JA; Hollinger HC; Fox M; Ince PG; McDermott CJ; Shaw PJ
    Neuropathol Appl Neurobiol; 2013 Aug; 39(5):562-71. PubMed ID: 23228179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of new ANG gene mutations in a large cohort of Italian patients with amyotrophic lateral sclerosis.
    Gellera C; Colombrita C; Ticozzi N; Castellotti B; Bragato C; Ratti A; Taroni F; Silani V
    Neurogenetics; 2008 Feb; 9(1):33-40. PubMed ID: 18087731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human angiogenin is a potent cytotoxin in the absence of ribonuclease inhibitor.
    Thomas SP; Hoang TT; Ressler VT; Raines RT
    RNA; 2018 Aug; 24(8):1018-1027. PubMed ID: 29748193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel Angiogenin gene mutation in a sporadic patient with amyotrophic lateral sclerosis from southern Italy.
    Conforti FL; Sprovieri T; Mazzei R; Ungaro C; La Bella V; Tessitore A; Patitucci A; Magariello A; Gabriele AL; Tedeschi G; Simone IL; Majorana G; Valentino P; Condino F; Bono F; Monsurrò MR; Muglia M; Quattrone A
    Neuromuscul Disord; 2008 Jan; 18(1):68-70. PubMed ID: 17703939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis.
    van Es MA; Schelhaas HJ; van Vught PW; Ticozzi N; Andersen PM; Groen EJ; Schulte C; Blauw HM; Koppers M; Diekstra FP; Fumoto K; LeClerc AL; Keagle P; Bloem BR; Scheffer H; van Nuenen BF; van Blitterswijk M; van Rheenen W; Wills AM; Lowe PP; Hu GF; Yu W; Kishikawa H; Wu D; Folkerth RD; Mariani C; Goldwurm S; Pezzoli G; Van Damme P; Lemmens R; Dahlberg C; Birve A; Fernández-Santiago R; Waibel S; Klein C; Weber M; van der Kooi AJ; de Visser M; Verbaan D; van Hilten JJ; Heutink P; Hennekam EA; Cuppen E; Berg D; Brown RH; Silani V; Gasser T; Ludolph AC; Robberecht W; Ophoff RA; Veldink JH; Pasterkamp RJ; de Bakker PI; Landers JE; van de Warrenburg BP; van den Berg LH
    Ann Neurol; 2011 Dec; 70(6):964-73. PubMed ID: 22190368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.